Navigation Links
PneumRx, Inc. Announces CE Mark Approval for Its RePneu® Lung Volume Reduction Coil (LVRC™) System
Date:10/13/2010

MOUNTAIN VIEW, Calif., Oct. 13 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has received CE Mark approval for its RePneu Lung Volume Reduction Coil (LVRC) System to treat the later stages of emphysema.  

The RePneu LVRC System is a minimally invasive device intended to improve lung function in emphysema patients by brochoscopically implanting Nitinol coils into the lungs to compress damaged tissue (lung volume reduction) and restore elastic recoil to the healthier lung tissue.  This treatment offers a minimally invasive alternative to lung volume reduction surgery, and works independently of collateral ventilation.  

The CE mark approval enables PneumRx to move forward with commercialization in Europe and other select markets.  PneumRx intends to launch its RePneu LVRC System in Europe in the last quarter of 2010.  PneumRx plans to continue its ongoing partnership with physicians through training and by offering novel products for the diagnosis and treatment of lung disease.

"We are thrilled to have achieved this important milestone, and look forward to introducing our RePneu LVRC to the European market to help improve the lives of so many people who are suffering from emphysema and have few other viable treatment options," said Erin McGurk, President and CEO of PneumRx, Inc.  "We are extremely pleased with the significant improvements in pulmonary function tests, exercise tolerance, and quality of life experienced by our clinical trial patients, and expect to bring these same benefits to a broader population of emphysema patients with the commercialization of the RePneu LVRC System in Europe."

About PneumRx, Inc.

PneumRx, Inc. is a rapidly growing medical device company focused on the development and commercialization of innov
'/>"/>

SOURCE PneumRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 A decade-long JDRF-funded study ... Zentrum München, Germany , is providing ... the risk of developing type 1 diabetes (T1D), highlighting ... the disease. The study, "Seroconversion to Multiple Islet Autoantibodies ... published today in The Journal of the American ...
(Date:6/19/2013)... 2013   Voices Against Brain Cancer (VABC), ... brain cancer, today announced that it has awarded Tocagen ... clinical investigation of Toca 511 & Toca FC in ... cancer (Grade 3 or Grade 4).  Tocagen is a ... cancer, with an initial focus on brain cancer. ...
(Date:6/19/2013)... 2013 Amerivet Solutions, LLC ( AMERIVET ... of government from Federal to Municipal, is pleased ... to include complex metal design and fabrication manufacturing. ... complex aluminum parts for the Defense Logistics Agency ... to service government contracts," states Richard Bergen ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Amerivet Solutions Expands to Manufacture Complex Metal Designs 2
... Dec. 3, 2010 It is natural that all customers ... high quality medicines, paying less for them and getting their ... of rxbuys.com is very timely and well-taken. This site assures ... faster service and guarantees of security. It uses the most ...
... AstraZeneca (NYSE: AZN ) ... and Drug Administration (FDA) Oncologic Drugs Advisory Committee ... for AstraZeneca,s investigational drug, vandetanib, for the treatment ... metastatic medullary thyroid cancer (MTC). ...
Cached Medicine Technology:A New Online Pharmacy rxbuys.com by RX Corp Offers its Services to International Clients 2US FDA Advisory Committee Makes Recommendation on New Drug Application for Vandetanib in Advanced Medullary Thyroid Cancer 2US FDA Advisory Committee Makes Recommendation on New Drug Application for Vandetanib in Advanced Medullary Thyroid Cancer 3
(Date:6/20/2013)... 2013 David Icke, the highly visible alternative ... Radio station. , Fresh from the Bilderburg fringe festival ... getting ready to launch ‘The Peoples Voice’ TV and Radio ... a fantastic opportunity for journalists to cover the stories and ... of the globe. , Because this station is for ...
(Date:6/20/2013)... Norwalk, CT (PRWEB) June 20, 2013 ... looking to energize their sales or test new markets, ... the U.S. now have a new sales outsourcing ... and sustained sales revenue. , Strategy Sales ... sales professionals. Founded by business owners for business owners, ...
(Date:6/20/2013)... June 20, 2013 The University of ... its new, online Master of Science in Nursing ... Master’s Education in Nursing from the American Association of ... the foundation of most major nursing master’s degree programs ... program from the University of Saint Mary not only ...
(Date:6/19/2013)... June 19, 2013 Paleo Burn has finally ... people finally sculpt the body they desire with no fad ... loss programs and health food products, Ken Smith was bold ... give consumers an easy, automatic, and permanent solution for weight ... details . , After a quick review of Paleo Burn, ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The Zac ... in the country and folk music genre. This band hails ... is the lead vocals and guitarist), Jimmy De Martini (working ... bass guitarist and in vocals), Coy Bowles (guitarist and keyboardist), ... Reyes (percussionist). The band was formed in 2002, but ...
Breaking Medicine News(10 mins):Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 3Health News:University of Saint Mary Launches New Online Master of Science in Nursing Built on the Latest AACN Essentials 2Health News:University of Saint Mary Launches New Online Master of Science in Nursing Built on the Latest AACN Essentials 3Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2Health News:Zac Brown Band Tickets for Raleigh, Columbia, Darien Center, Gilford, Minneapolis, Holmdel, Pittsburgh, Camden, Atlanta, Boston, Bethel, Toronto & Hartford Now Available 2
... of great public health importance in tropical countries. James ... episodes are associated with transient increases of HIV-1 viral ... episodes might accelerate HIV-1 disease progression and facilitate transmission. ... effects of HIV-1 infection on malaria. In pregnant women ...
... Toyama University, Japan have found that supplementation of fish ... //Researchers have found that Docosahexaenoic acid (DHA), which is ... component of cell membranes of the retina and brain. ... have lower concentrations of DHA in blood. , ...
... colleagues from United Kingdom have found a new antibiotic ... of Tetracycline known as Glycycline. // ,Due to ... of antibiotic resistance shown by many organisms. Staphylococcus aureus ... cause of concern as it causes most of the ...
... continues to grow and currently affects more that ... emphasize a need for alternative diabetes therapies with ... ,The delivery of insulin by the lung may ... diabetes. However, alternative insulin delivery systems must meet ...
... Bird Flu epidemic that is causing chaos in Turkey and ... the viral strain H5N1//. , ,The migratory bird ... affected by the deadly virus strain H5N1 that can kill ... due to the direct contact with affected and sick birds. ...
... hematopoietic-cell transplantation with the use of conditioning ... to decrease early toxic effects extends the ... than 50 years and those with coexisting ... (GVHD) remains a major problem after non-myeloablative ...
Cached Medicine News:Health News:Malaria infection can accelerate HIV infection and disease progression 2Health News:Tigecycline – New Generation Tetracycline With Broad Spectrum Antibacterial Activit 2Health News:HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy 2Health News:Protective regimen for acute Graft-versus-host disease 2
The Avant® 9700 combines flexible alarm options, unparalleled non-volatile memory, and Nonins time-honored technology to give you an easy-to-use and efficient monitor....
... Resolve Immersion Oil is a clear, ... throughout most of the UV-VIS spectrum. ... and high viscosity, is non-drying and ... of 1.5150. Resolve contains no PCBs, ...
Immersion Oil, 150 cs...
Immersion oil for microscopy...
Medicine Products: